[Clinical experiences with SP-I].
D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011033:Podophyllin / Q000627:therapeutic use; D011035:Podophyllum / Q000627:therapeutic use*
D011033:Podophyllin